Friday, November 20, 2015

EXPERIMENTAL REPORT: 1 Effect of alprazolam (0.5 mg) on driving performance of anxiety patients and healthy controls Effect of alprazolam (0.5 mg) on driving performance of anxiety patients and healthy controls

TITLE: Effect of alprazolam (0.5 mg) on driving performance of anxiety patients and healthy controls
AUTHOR: Katerina Touliou, Dr. Evangelos Bekiaris, Dr. Maria Panou
JOURNAL: International Conference on Alcohol, Drugs and Traffic Safety (T2013), 20th, 2013, Brisbane, Queensland, Australia.
ABSTRACT:In the present study the major objective was to investigate the effect of alprazolam in treated and untreated anxiety patients compared to a healthy control group after oral alprazolam administration (0.5 mg) (acute phase) in a simulated environment. Primary variables were the vehicle variables (driving performance measures). The secondary objective was to compare multiple cognitive and subjective measures collected for each participant in order to establish the whole range of driving impairment.(Full text here)

MY TAKE:This study demonstrates that a common medication used for anxiety reduces driving performance.

No comments: